Rebel Medicine Secures Funding to Propel Non-Opioid Pain Therapeutics into Clinical Trials Rebel Medicine Inc has announced the successful closing of a $6 million Series A financing, opening new avenues for non-opioid pain management therapies.

Rebel Medicine Secures Funding to Propel Non-Opioid Pain Therapeutics into Clinical Trials #USA #Salt_Lake_City #Rebel_Medicine #Alevatrix #pain_therapy